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B cell responses to mitogens or polyclonal B cell activators have been extensively 
studied because it is believed that such responses may provide valuable basic infor- 
mation regarding B cell differentiation (1), B cell subsets (2, 3), B cell functions (4, 5), 
and  roles  of B  cells  in  autoimmune  disease  (6-8).  There  is  some  evidence  that 
responsiveness to B cell mitogens is genetically determined.  However, unlike T  cell- 
dependent  immune responses  (9), B cell responses to mitogens in the mouse do not 
appear to be under control of genes located in the major histocompatibility complex. 
For  example,  the  inbred  strains  of  mice  C3H/HeJ  (10)  and  CBA/N  (1 1)  are 
unresponsive  or  poorly  responsive  to  bacterial  lipopolysaccharide  (LPS), ~ a  well- 
known B cell mitogen. The C3H/HeJ defect has been mapped to a single autosomal 
locus that is not linked to the H-2 region (12), whereas the CBA/N defect is known to 
be due to an X-linked recessive gene (11,  13). 
To further elucidate the genetic factors regulating B cell responsiveness to mitogens, 
we have tested splenic lymphocytes from a  panel of inbred strains of mice for their 
proliferative  responsiveness  to  a  B  cell  mitogen  derived  from  Actinomyces  viscosus 
(AVIS). In the course of these screening experiments, we discovered that spleen cells 
from the  SM/J  strain  exhibited  dramatically high proliferative responses to AVIS 
mitogen. Further experiments disclosed that SM/J mice are hyperresponsive to LPS 
and other B cell mitogens as well. The studies reported here establish that the high 
proliferative  response  to  mitogens  is  under  polygenic,  non-H-2-1inked,  autosomal 
genetic control. Furthermore, this genetic control appears to be expressed through the 
B  cell  because T  lymphocytes or macrophages do  not  affect the  high  proliferative 
responses in vitro. In a  future, related report,  2 we describe the significantly elevated 
natural killer cell activity in SM/J mice and its relationship to hyperresponsiveness of 
B cells to mitogens. 
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Materials and Methods 
Mice.  Mice used for initial screening experiments were obtained from The Jackson Labo- 
ratory, Bar Harbor, Maine, and were between 8 and 20 wk of age. The SM/J and C57BL/6J 
(B6)  mice used in subsequent studies were bred in our colony by brother-sister mating from 
breeding stock obtained from  The Jackson  Laboratory. The  F~  progeny of B6  female and 
SM/J male mice and the backcross progeny of (B6 ×  SM)F1 females and B6 males were bred 
in our colony. 
Mitogens.  A crude homogenate from A. viscosus bacteria has prevously been shown to be a 
potent  B  cell mitogen in mice  (14).  For these experiments, we prepared a  soluble cell-wall 
extract of the homogenate, which contains ~90% of the mitogenic activity, using a modification 
of the  trichloroacetic acid extraction  method  of Schleifer and  Kandler  (15),  as previously 
described (16). 
LPS from Escherichia  coli 055:B5 (Westphal extract) and phytohemagglutinin P  (PHA) were 
obtained from  Difco Laboratories, Detroit,  Mich.  Purified protein derivative of tuberculin 
(PPD) was obtained from the National Institute of Allergy and Infectious Diseases, Bethesda, 
Md. Dextran sulfate (DxS), type 500-S, was obtained from Sigma Chemical Co., St. Louis, Mo. 
Lymphocyte  Preparation  and  Culture  Conditions.  Spleen cells were prepared as previously de- 
scribed (14)  and were suspended in RPMI  1640  medium containing penicillin (100  U/ml), 
streptomycin (100/zg/ml), 4 mM Hepes buffer, and 5% heat-inactivated normal human serum. 
Cells were dispensed in 0.1-ml vol into the wells of microtest plates (3040;  Falcon Labware, 
Div.  of Becton,  Dickinson & Co., Oxnard, Calif.). Mitogens were suspended in medium at 
appropriate concentrations and added to the Wells in 0.1-ml vol at the start of the cultures. The 
cells were cultured for 48  h  at  37°C  in  a  humidified atmosphere at  5%  CO2  in air. DNA 
synthesis was measured as described elsewhere (16). In previous experiments we demonstrated 
that optimal DNA-synthesis responsiveness of C57BL/6J mouse splenoeytes to AVIS and LPS 
mitogens occurs on the 2nd  d  of culture (14).  Optimal mitogen dosage was found in those 
experiments to be  100/zg/ml  of AVIS or of LPS.  Therefore,  in the screening experiments 
reported here, we used 2 d  of culture and a  mitogen dosage of I00/~g/ml. We subsequently 
verified that the mitogenic response of SM/J cells was also greatest on day 2 of culture and that 
optimal mitogen doses were similar for SM/J and B6 mice. 
Removal  of B  Cells.  B  lymphocytes were removed from splenoeyte preparations by three 
different techniques: (a) antibody-complement lysis: cell surface immunoglobulin-positive cells 
were lysed by incubating 10  splenocytes with 1 ml of a  1:15 dilution of goat anti-mouse Ig for 
45 min at 4°C. The cells were washed and incubated 30 rain at 37°C at a concentration of 106 
cells/ml with  a  1:10  dilution of rabbit complement  (Low-Tox-M; Cedarlane Laboratories, 
Hornby,  Ontario,  Canada).  (b)  Nylon  wool  column:  B  lymphocytes were  removed  from 
splenocyte preparations by two passages through nylon wool columns, as previously described 
(17). (c) Rosetting: B cells were selectively  removed by rosetting with sheep erythroeytes coupled 
with affinity-purified antibody to mouse Ig using the technique of Walker (18). 
Removal of T  Cells and Macrophages.  T  lymphoeytes were removed from splenocyte prepara- 
tions using rabbit anti-rat brain antiserum and complement (19). Macrophages were removed 
by adherence to petri dishes for 1.5 h at 37°C using medium containing 15% fetal calf serum 
(FCS). The nonadherent cells were withdrawn from the dish, washed twice, and resuspended 
in medium containing 5% normal human serum. As a  second method of eliminating macro- 
phages, silica powder was added in a  concentration of 50 ~g per microcuhure, as previously 
described (20). Silica is selectively toxic for macrophages (21). 
Immunofluorescence.  The percentage of B cells present in splenocyte preparations was deter- 
mined by immunofluorescent  staining for cell surface immunoglobulin. Approximately l0  s 
viable cells in  50/zl of serum-free medium were incubated with  25 /~1 of either fluorescein- 
conjugated,  affinity-purified Fab'  fragments  of a  goat  anti-mouse  Fab  antiserum  or  with 
rhodamine-conjugated  (Fab')2  goat  anti-mouse  IgM  (heavy  chain  specific;  N.  L.  Cappel 
Laboratories, Coehranville, Pa.)  for 30  min.  T  cells were detected by staining in  the same 
manner with fluorescein-conjugated Fab' fragments of rabbit anti-rat brain antibody. The cells 
were counted under the fluorescence microscope as previously described (22). 
H-2  Typing.  Mouse alloantisera against H-2 b and 1t-2 v private specificities were obtained 
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Infectious  Diseases,  Bethesda,  Md. H-2 typing of spleen cells of (SM  X  B6)F1  ×  B6 backcross 
progeny  and  parental  and  Ft controls was done using a  two-step  cytotoxicity technique  with 
specific ailoantisera  and a  1:15 dilution of rabbit complement  (Low-Tox-H,  Cedarlane  Labo- 
ratories). 
Results 
Hyperresponsiveness of SM/J  Splenocytes to  AVIS and  Other B  Cell Mitogens.  These 
studies  began  as  a  screening  experiment  in  which  two  mice  from  each  of several 
different strains were  tested for splenocyte proliferative responsiveness to AVIS,  a  B 
cell  mitogen.  As  a  positive  control  and  for comparative  purposes,  each  assay  also 
included cultures of splenocytes from B6 mice because the AVIS-induced response of 
these animals had previously been thoroughly characterized  (14). The results of the 
screening experiment  are  shown  in  Fig.  1.  No strains  were  unresponsive;  although 
there were  minor variations in the magnitude of response  in individual mice,  most 
strains  did  not differ  remarkably  from each other or from  the control  B6 mice.  In 
sharp  contrast  was  the  very  high  response  of the  SM/J  strain.  The  proliferative 
response  of splenocytes  from  SM/J  mice  was  found  to  be  approximately  five-  to 
eightfold higher than the responses of all the other strains tested. 
We next tested the proliferative responses of SM/J splenocytes to LPS,  DxS, and 
PPD  to distinguish whether the high response of SM/J  was  restricted  to AVIS,  or 
whether SM/J was a higher responder to several B cell mitogens. As shown in Table 
I, the responses to all of the B cell mitogens that we tested were also severalfold higher 
than the responses of B6 splenocytes to the same mitogens. It is important to note that 
TEST 
H-2  STRAIN 
bc  B10.129 
d  B10.O2 
f  B10.M 
g  HTG 
h  B10.A(2R) 
i  BIO.A(SR)  - 
ja  B10.WB 
k  AKR,'J 
m  B10,AKM 
o  C3H-H-2  ° 
pa  B10.Y 
q  SWR/J 
r  BIO.R Ig 
r  RIB/J 
s  SJL 
u  B10.PL 
v  B10.SM 
v  SM/J 
~o 
~o 
ale!  I 
18 
dP 
it'8 
8eo 
IB 
8'e o 
Oil 
•  O 
=P 
t 
~o 
O 
O 
~0  do  do  1~0 
CPM  x  10 -3 
FIc.  1.  The  AVIS-induced  proliferative  responsiveness  of splenocytes  from  a  panel  of inbred 
mouse strains.  4  x  105 cells/well were cultured for 48 h  in the presence or absence of 100 #g/ml of 
AVIS mitogen. The ceils received a pulse of z~I-deoxyuridine 4 h before harvest. The data represent 
the mean counts per minute (cpm) of six replicate AVIS-stimulated cultures minus the mean cpm 
of six replicate nonstimulated cultures. Nonstimulated cultures were generally in the range of 200- 
1,200  mean cpm.  Each  point  represents the  data  from one  animal.  Symbols:  C),  test  strain;  0, 
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TABLE I 
Comparison of the SM/J and C57BL/6J Responses to Several B Celt Mitogens and 
to PHA 
729 
Experiment  Mitogen:~ 
DNA synthesis* 
SM/J  C57BL/6J 
Medium control  845 (133)  1,382 (282) 
AVIS  159, 113 (4,018)  7,098 (580) 
LPS  160, 518 (14,596)  12, 660 (2,528) 
PHA  16, 187 (1,765)  21,397  (2,525) 
Medium control  1,898 (271)  223 (49) 
AVIS  79, 861 (7,811)  9, 841 (1,582) 
DxS  17,977 (1,867)  1,299 (154) 
PPD  48, 870 (5,822)  6, 492 (1,516) 
* Cultures containing 4 ×  105 splenocytes per microtest well were pulsed for the final 
4 h of 48-h culture periods with 0.5 #Ci of 125IUdR. The data represent the mean 
cpm (SD) of radiolabel incorporated by six replicate cultures. 
Mitogen concentrations: AVIS and LPS, 100/~g/ml; PHA, 10 #g/ml; DxS, 50 #g/ 
ml; PPD, 100 ~tg/ml. 
the response of SM/J splenocytes to PHA, a T  cell mitogen, was not higher than that 
of B6 splenocytes. This finding of normal PHA responsiveness is in agreement with a 
previous report (23). 
Genetic Analysis.  No sex-linked differences in B cell responsiveness were evident in 
SM/J mice because both male and female mice were found to be hyperresponsive to 
B cell mitogens. The responsiveness to AVIS and LPS of (B6 ×  SM)F1 progeny were 
compared to age- and sex-matched B6 and  SM/J  parental  mice; the results of two 
such experiments, using AVIS mitogen, are shown in experiments  1 and 2 of Fig.  2. 
The  F1  mice consistently  exhibited  a  mitogenic  response  to AVIS  intermediate  in 
magnitude  compared with  the responses of the  parental  strains.  The LPS-induced 
responses were also intermediate  (data not shown). These findings demonstrate that 
hyperresponsiveness in SM/J mice is genetically determined. The observed interme- 
diate  responsiveness  of the  F1  mice  is  consistent  with  a  gene-dosage  effect,  with 
semidominant expression of the SM high-response genes. 
The B10.SM congenic-resistant strain that carries the SM/J H-2 ° haplotype is not 
a  high  responder  strain  to  B  cell  mitogens  (Fig.  1).  This  suggests  that  the  genes 
conferring  high  responsiveness  in  SM/J  mice  are  not  present  on  the  segment  of 
chromosome  17 transferred to B 10.SM.  To definitively test H-2 linkage of the high 
response genes, (B6 X SM)F~ ×  B6 backcross progeny mice were H-2 typed and their 
splenoeyte proliferative responsiveness to AVIS and LPS was determined. Proliferative 
responsiveness  to  AVIS  by  splenocytes  from  backcross  mice  was  compared  with 
SM/J,  (B6 ×  SM)F1, and B6 mice. The results are shown in experiments 3-7 of Fig. 
2. In general, the magnitude of the AVIS responses of backcross mice was intermediate 
to that of the Fx and the B6 mice. Similar results were observed using LPS as a B cell 
mitogen (data not shown). The results indicate that the high responsiveness of SM/J 
is  under  polygenic  control;  backcross  mice  did  not  segregate  into  two  discrete 
responder groups ("high" and  "low") as would  be expected for single gene control. 
Only  1 of the 36 backcross progeny tested had a  response similar to the F1 parental 
mice. Comparison of the  mitogenic responses of H-2 b/v  and  H-2 b/b  backcross mice 730 
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Ftc~.  2.  Analysis of the AVIS-induced proliferative responsiveness  of splenoeytes from (B6 ×  SM)FI 
apnd (B6  X SM)FI ×  B6 backcross mice. Culture conditions were the same as described in Fig.  1. 
The data represent the mean cpm of six replicate AVIS-stimulated cultures minus the mean cpm 
of six replicate nonstimulated cultures. Nonstimulated cultures were generally in the range of 200- 
1,200 mean cpm. Experiments 1 and 2 compare the (B6  ×  SM)FI responses with the responses of 
SM/J and B6 parental strains. Experiments 3-7 compare the responses of backcross mice with the 
responses of SM/J, F~, and B6 mice. Symbols: O, SM/J; A, (B6 X SM)Fx; I,  (B6 X SM)F1 X B6 
backcross; O, B6. 
TABLE II 
Lack of Association between H-2 Type and Mitogenic Responses in (B6 X 
SM)F1  ×  B6 Backcross Mice 
H-2  Number of  DNA synthesis* 
genotype:[:  mice  AVIS§  LPS§ 
b/b  20  18,741  (2,268)  31,189 (3,121) 
v/b  16  17,478  (2,438)  30,073  (3,571) 
* Splenoeytes were cultured as described in Table I, and DNA synthesis was 
quantitated by incorporation of a  pulse of ~2sIUdR.  Data are expressed as 
the mean cpm (SEM). 
~: Genotypes were determined by a cytotoxicity assay using specific antisera to 
K and D alloantigens and rabbit complement. 
§ AVIS and LPS mitogens were used at  100 #g/ml. 
confirmed that the high responsiveness to B cell mitogens was not H-2 linked  (Table 
II). There were no differences in the mean responses or range of responses of these two 
groups. 
High Responsiveness Is Not  T  Cell or Macrophage Dependent.  Although earlier studies 
using B6 mice had shown the AVIS-induced proliferative response of splenocytes to 
be T  independent  (14), it was possible that T  cells in the SM/J strain may have been 
participating in some way, such as by providing an enhancing signal.  Therefore, T 
cells  were  selectively  eliminated  from  SM/J  splenocyte  suspensions  by  lysis  with 
antibody and complement, and the response of  such T-depleted cultures was compared D.  ENGEL,  E.  A.  CLARK,  L.  HELD,  H.  KIMBALL,  AND  J.  CLAGETT  731 
with the response of intact SM/J splenocytes. As shown in experiment 1 of Table III, 
T cell depletion did not reduce the hyperresponse to AVIS, suggesting that T cells are 
not required. 
The  role  of macrophages  in  proliferative  responses  of AVIS  and  LPS  B  cell 
mitogens, although negligible in CBA/J and C57B6/J  mice (J.  Clagett, K. Smith, 
and C. Rosse, manuscript in preparation), remained a possibility in SM/J mice. We 
therefore did experiments in which macrophages were removed by either adherence 
to  plastic  or  poisoning  with  silica.  The  results  of these  experiments  (Table  III; 
experiments 2 and 3)  illustrate that hyperresponsiveness to AVIS or LPS in SM/J 
mice is not reduced by removal of macrophages. 
Removal of B Cells Abrogates Hyperresponsiveness.  The experiments above support the 
hypothesis that hyperresponsiveness of SM/J splenocytes is due to an abnormality in 
the  B  cell population  rather than to an  unusual T  cell- or macrophage-mediated 
enhancement of the B cell response. To definitively prove that the high response was 
due only to B cell proliferation, B lymphocytes were selectively removed from SM/J 
splenocyte suspensions by antibody-complement lysis, nylon wool, or rosetting tech- 
niques  before mitogen stimulation.  The  results  are  shown  in  Table  IV.  All  three 
methods used to remove B cells (antibody and complement lysis, passage of spleen 
cells through nylon columns, and rosetting B cells with c~Ig-coated sheep erythrocytes) 
effectively abrogated responsiveness to LPS.  It is unlikely, therefore, that  SM/J T 
ceils or macrophages are proliferating in response to B mitogens; rather the observed 
high DNA synthesis response of SM/J splenoeytes is due to elevated B cell prolifera- 
tion. This was confirmed by immunofluorescent and electron microscopic examination 
of cells from intact SM/J splenocyte cultures 2 and 4 d after LPS stimulation. The 
vast majority of such cells (~80%) were immunoglobulin-producing cells with the fine 
structural features of B blasts or plasma cells.  We did not observe any cells with T 
blast morphology. 
Percentages of B  and  T  Cells in  SM/J  Spleens.  To  determine  whether  the  high 
TABLE III 
Failure of Removal of T Cells or Macrophages to Abrogate High Response of SM/J Splenocytes to B Cell 
Mitogens 
Experi-  Method 
ment 
DNA synthesis* 
Medium 
Cells  AVIS  LPS  PHA  Con A  control 
t  RARB +  C:~  Intact  839 (102)  74,390 (5,496)  NI~  11,763 (1,741)  ND 
T Cells removed  319 (50)  100,120 (10,996)  ND  335 (92)  ND 
2  Adherencell  Intact  4,302  (352)  47,681  (7,813)  103,381  (4,270)  ND  43,081  (5,082) 
Mq~ removed  3,715  (436)  54,670  (4,811)  92,739 (7,043)  ND  25,382  (3,883) 
3  Silica¶  Intact  521 (140)  ND  42,762  (4,835)  20,044  (5,723)  122,671 (12,939) 
M 0  removed  527 (151)  ND  51,145  (3,278)  22,339  (8,450)  91,674  (7,729) 
* Culture and radiolabeling conditions were as described in Table I. Mitogen concentrations: AVIS and LPS, 100 ttg/ml; PHA, 10 .ag/ml; concanavalin 
A (Con A), 2.5/zg/mL The data are presented as mean cpm (SD) of radiolabel incorporated by six replicate culture~. 
:~ T cells were removed by treatment of the splenocytes with rabbit anti-rat brain (RARB) and complement (19). The remaining cells were washed and 
resuspended at the same concentration as control (untreated) splenocytes. 
§ ND, not determined. 
]] Macrophages  (Mq~) were removed by preincubation of splenocytes on plastic petri dishes for  1.5 h  at 37°C in medium containing  15% FCS. The 
nonadherent cells, containing <3% phagocytes, were collected and resuspended at the same concentration as control cells in medium containing 5% 
normal human serum. 
¶ M~ were killed by addition of 50 u.g of silica per microculture (20). 732  HYPERRESPONSE  TO  B  CELL  MITOGENS  IN  SM/J  MICE 
TABLE  IV 
Abrogation of High Response of SM/J Splenocytes to LPS by Removal of B Cells 
Experi-  Method 
ment 
DNA synthesis* 
Medium  Cells  LPS  PHA  Con A  control 
1  alg +  C:~  Intact  936 (227)  96,370 (4,116)  ND§  266,400 (56,700) 
B cells  681 (208)  16,189 (2,380)  ND  213,973 (74,820) 
removed 
2  Nylon woolll  Intact  253 (46)  47,801  (8,497)  4,413 (672)  78,408 (10,073) 
B cells  117 (49)  516 (68)  15,303 (908)  28,150 (4,617) 
removed 
3  Rosette¶  Intact  378 (45)  55,551  (4,547)  ND  85,743 (5,313) 
B cells  509 (119)  3,142 (182)  ND  68,905 (7,757) 
removed 
* Culture and radiolabeling conditions were as described in Table I. Mitogen concentrations: LPS,  100 #g/ 
ml; PHA,  10 #g/ml; concanavalin A  (Con A), 2.5 #g/ml. The data are presented as mean cpm (SD) of 
radiolabel incorporated by six replicate cultures. 
~: B  cells were lysed by treatment with goat-anti-mouse Ig (light chain specific)  and rabbit complement. 
The  remaining  cells  were  washed  and  resuspended  at  the  same  concentration  as  control  (intact) 
splenocytes. 
§ ND, not determined. 
II Splenocytes were passed twice over a nylon wool column to remove B cells (17). 
¶ B cells were selectively removed by rosetting with erythrocytes coupled with antibody to mouse Ig (18). 
TABLE g 
Comparison of the Percentages  of B and T Ceils in Spleens of SM/J and 
C57BL/ 6J Mice 
Fluorescent reagent* 
Percentage of surface-stained cells:l: 
SM/J  C57BL/6J 
Anti-Fab  51.6 (6.9)  55.8 (6.8) 
Anti-#  48.6 (1.7)  52.2 (2.9) 
Anti-T cell (RARB)  28.9 (3.5)  27.4 (3.4) 
* B  cells were  detected  by staining viable cells with either affinity-purified 
anti-Fab  antibodies or anti-# specific  antiserum.  T  cells were  detected  by 
staining viable cells with rabbit anti-rat brain (RARB)  antiserum (19). 
:~ The data are the mean values (SD) from three independent experiments. All 
mice were 8 wk of age. 
mitogenic response was due to a higher than normal ratio of B cells to T  cells in the 
SM/J spleen, we compared the cell surface phenotypes of SM/J and B6 splenocytes. 
Splenocytes from mice of each strain were stained with fluoresceinated antibodies to 
B  and T  cell  markers and were examined  by fluorescence microscopy. The results 
show that the percentages of splenic B and T  cells were not significantly different in 
the two strains of mice (Table V). 
Discussion 
Our studies show that splenic B lymphocytes from SM/J mice undergo an unusually 
high proliferative response to several polyclonal B cell activators. It is unlikely that T D. ENGEL, E. A. CLARK, L. HELD, H. KIMBALL,  AND J. CLAGETT  733 
cells  or  maerophages  play an  enhancing role  in  this  high  response  because  their 
depletion from cultures does not alter the magnitude of response  (Table  III).  We 
must, however, add the caveat that very small numbers of T  cells or macrophages 
may be present in depleted cultures and that these few cells may contribute something 
essential to the high response. We do not believe that high responsiveness is due to a 
lack of, or reduced numbers of, suppressor T  cells because the addition of varying 
numbers of splenocytes from normal  responder  B10.SM  mice  (which  presumably 
have normal suppressor T  cells)  to cultures of SM/J splenocytes does not reduce the 
magnitude of the mitogenic response (unpublished results). We cannot rule out the 
possibility that SM/J B cells lack a functional receptor that is necessary for recognition 
of a regulatory signal. However, this too seems unlikely because the mice do not have 
hypergammaglobulinemia, leukocytosis, splenomegaly, or any apparent autoimmune 
diseases (see below). 
Hyperresponsiveness to B cell mitogens in SM/J mice is genetically determined. 
The responses of (B6 X SM)F1 mice to LPS and AVIS were intermediate compared 
with SM/J and B6 parents (Fig. 2); this suggests that a gene dosage effect is operative 
in the F1 mice (expression at 50% of SM/J levels of a  critical enzyme or receptor). 
Analysis of individual segregating (B6  ×  SM)Fx  ×  B6 backcross progeny indicates 
that hyperresponsiveness to B cell mitogens is under polygenic control in SM/J mice 
and that these genes are not linked to the H-2 complex (Table II). However, the lack 
of a role for H-2 in hyperresponsiveness of SM/J mice to the B cell mitogens LPS and 
AVIS  does  not  preclude  the  possibility that  H-2-1inked  genes  may influence the 
response to other B cell mitogens in other strains of mice. Relatively little is known 
about genes controlling responsiveness to B lymphocyte mitogens. The best charac- 
terized genes that influence LPS responsiveness are the Lps a gene (12) of the C3H/ 
HeJ strain and the xid gene of the CBA/N strain (11, 13). We are presently developing 
and  testing Fx  hybrids between  C3H/HeJ,  CBA/N,  and  SM/J  to  determine  the 
influence of the Lps a and xid genes on the expression of the SM/J  hyperresponse 
genes. 
B  lymphocytes are  heterogeneous, and  there  is  evidence based  upon  sequential 
stimulation with various different mitogens and upon suicide experiments that subsets 
of B cells respond optimally to different B cell mitogens (24-26). However, Andersson 
et al.  (27) have postulated that there may also be a  B cell subset that expresses all 
mitogen receptors of a species and therefore responds to all mitogens. Because SM/J 
mice are hyperresponsive to four different B cell mitogens, which putatively activate 
different B  cell  subsets,  there are  at  least  three  possible  models to explain SM/J 
hyperresponsiveness:  (a)  a  general expansion  of all  B  cell subsets that  respond  to 
mitogens;  (b)  specific  expansion  of the  B  cell  subset  that  has  muhiple-mitogen 
reactivity (27);  (c) all subsets are normal in proportion, but the cell cycle of B cells in 
response to mitogens is shortened so that multiple rounds of DNA synthesis occur. 
These possibilities may be tested by using the 5-bromo-deoxyuridine suicide technique 
as  described  by  Bona et  al.  (26) and  by cell-cycle analysis using  flow cytometry 
techniques (28). 
SM/J  mice provide a  unique and potentially useful model system for testing a 
variety of questions  regarding  B  cell  triggering,  differentiation, and  function.  In 
contrast to other strains with high spontaneous polyclonal B cell responsiveness--such 
as the motheaten (29-30),  NZB, and MRL/1 strains (31)--SM/J  mice are healthy 734  HYPERRESPONSE TO B CELL MITOGENS IN SM/J  MICE 
and have normal life spans with no detectable autoimmune disease processes. It has 
been reported that natural IgM thymocytotoxic antibodies are markedly elevated in 
SM/J mice, particularly in old females; however, SM/J mice do not have antinuclear 
antibodies  or elevated  serum  IgM  levels,  and  they  do  not  develop systemic lupus 
erythematosus-like syndrome  (32).  We  have  screened  several  animals  for  immune 
complex deposition  in  the kidney and  have found  no evidence of this symptom of 
autoimmune disease. Serum levels of IgG are also similar for SM/J and B6 mice and 
do not increase significantly in aged SM/J animals. Furthermore, we have examined 
the kidneys of 10 aged mice (10-17 mo old) for amyloid by Congo red staining, and, 
in contrast  to a  previous anecdotal  report  (33),  we have not  found any evidence of 
amyloidosis.  The  lack  of  autoimmunity  in  SM/J  mice  suggests  that  in  spite  of 
hyperresponsiveness to B cell mitogens in vitro, they do possess an effective immuno- 
regulatory system in vivo. 
Summary 
We tested the proliferative responses of splenocytes from a  panel of inbred mouse 
strains to AVIS, a  B cell mitogen from Actinomyces viscosus  bacteria. The SM/J strain 
was found to exhibit severalfold higher responsiveness than any of the other strains. 
SM/J splenocytes were also hyperresponsive to the B cell mitogens lipopolysaccharide, 
dextran sulfate, and purified protein derivative of tuberculin,  but  responsiveness to 
the  T  cell  mitogen  phytohemagglutinin  was  normal.  (B6  ×  SM)Fa  and  Fx  X  B6 
backcross mice were tested  for AVIS and  lipopolysaccharide responsiveness, and  it 
was determined that hyperresponsiveness was under polygenic, autosomal, non-H-2- 
linked gene control. Genetic control of response to B mitogens in SM/J mice appears 
to be expressed solely through the B lymphocyte because removal of T  lymphocytes 
or macrophages did not reduce the magnitude of responsiveness in vitro. SM/J mice 
may provide a  useful model for testing questions regarding B cell triggering,  differ- 
entiation, and function, and to examine the genes involved with B cell proliferation. 
We are grateful to Dr. Sharyn Walker for technical assistance  in experiments where B cells 
were selectively removed by rosetting with Mg-eoated sheep erythrocytes, to Dr. Tom Stanton 
and Dr. Ursula Storb for critical review of the manuscript, and to Ms.  Alexis Raphael for 
manuscript preparation. 
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